Insider · CIK 0001242613
MAYLEBEN TIMOTHY M
Reports to the SEC for 7 companies · ANN ARBOR, MI
Transactions
50
Companies
7
Filings
3
CIK
0001242613
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-02-11 | MARINUS PHARMACEUTICALS, INC.D Disposition to Issuer | −$1,265 |
| 2025-02-11 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-11 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-11 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-11 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-11 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-11 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-11 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-11 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-11 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-11 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-11 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-07 | MARINUS PHARMACEUTICALS, INC.D Disposition to Issuer | −$2,530 |
| 2025-02-07 | MARINUS PHARMACEUTICALS, INC.D Disposition to Issuer | −$5,850.35 |
| 2025-02-07 | MARINUS PHARMACEUTICALS, INC.D Disposition to Issuer | −$913 |
| 2025-02-07 | MARINUS PHARMACEUTICALS, INC.D Disposition to Issuer | −$913 |
| 2024-10-10 | MARINUS PHARMACEUTICALS, INC.G Gift | — |
| 2024-10-10 | MARINUS PHARMACEUTICALS, INC.G Gift | — |
| 2024-10-10 | MARINUS PHARMACEUTICALS, INC.G Gift | — |
| 2024-06-18 | MARINUS PHARMACEUTICALS, INC.A Award | — |
| 2024-06-18 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award | — |
| 2024-05-23 | Landos Biopharma, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2024-05-23 | Landos Biopharma, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2024-01-18 | MARINUS PHARMACEUTICALS, INC.A Award | — |
| 2024-01-18 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award | — |
| 2023-05-23 | Landos Biopharma, Inc.Stock Option (right to buy)A Award | — |
| 2023-01-26 | MARINUS PHARMACEUTICALS, INC.A Award | — |
| 2023-01-26 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award | — |
| 2022-06-17 | Landos Biopharma, Inc.Stock Option (right to buy)A Award | — |
| 2022-02-04 | MARINUS PHARMACEUTICALS, INC.A Award | — |
| 2022-02-04 | MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award | — |
| 2021-12-17 | Landos Biopharma, Inc.Stock Option (right to buy)A Award | — |
| 2021-05-13 | Landos Biopharma, Inc.Stock Option (right to buy)A Award | — |
| 2021-01-28 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2021-01-15 | MARINUS PHARMACEUTICALS, INC.Stock option (right to buy)A Award | — |
| 2020-12-30 | ESPREsperion Therapeutics, Inc.M Exercise/Conversion | +$22.4K |
| 2020-12-30 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
| 2020-03-11 | ESPREsperion Therapeutics, Inc.P Purchase | +$108K |
| 2020-02-28 | ESPREsperion Therapeutics, Inc.P Purchase | +$245K |
| 2020-01-08 | MARINUS PHARMACEUTICALS, INC.Stock option (right to buy)A Award | — |
| 2020-01-02 | ESPREsperion Therapeutics, Inc.A Award | — |
| 2020-01-02 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2019-11-15 | ESPREsperion Therapeutics, Inc.G Gift | — |
| 2019-11-11 | ESPREsperion Therapeutics, Inc.G Gift | — |
| 2019-11-06 | ESPREsperion Therapeutics, Inc.P Purchase | +$185K |
| 2019-09-06 | ESPREsperion Therapeutics, Inc.P Purchase | +$88.1K |
| 2019-09-04 | ESPREsperion Therapeutics, Inc.P Purchase | +$166K |
| 2019-09-04 | ESPREsperion Therapeutics, Inc.P Purchase | +$4,946.16 |
| 2019-08-01 | ESPREsperion Therapeutics, Inc.P Purchase | +$198K |
| 2019-06-28 | ESPREsperion Therapeutics, Inc.P Purchase | +$230K |
Recent filings
- 4MAYLEBEN TIMOTHY M0001104659-25-011242SEC(opens sec.gov)
- 4MAYLEBEN TIMOTHY M0001415889-24-025070SEC(opens sec.gov)
- 4MAYLEBEN TIMOTHY M0001415889-24-017639SEC(opens sec.gov)
Companies
Address
PO BOX 376
ANN ARBOR, MI, 48106